Jacqueline Kelly
Papers
1
Total Citations
2
H-Index
1
About
Dr. Jacqueline Kelly is a leading clinical researcher in head and neck oncology, with a particular focus on human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. Her work critically examines treatment paradigms for this increasingly prevalent cancer, comparing the efficacy of upfront surgery versus definitive chemoradiation therapy. In her most-cited study, "Survival Outcomes Among Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Patients Treated with Upfront Surgery Versus Definitive Chemoradiation Therapy" (2017), Dr. Kelly provides essential comparative data that informs clinical decision-making for patients and oncologists. While her citation count is modest, her contributions are significant in refining treatment strategies for HPV-positive disease, a rapidly evolving field where personalized therapy is paramount. Dr. Kelly’s research underscores the importance of balancing oncologic outcomes with quality of life, offering evidence that helps guide multidisciplinary care. Her work is particularly valuable for trainees and practitioners seeking to understand the nuances of managing HPV-associated oropharyngeal cancers, and it continues to influence ongoing debates about optimal treatment sequencing in this patient population.
Research Focus
Key Achievements
Top Papers
- 1